AstraZeneca PLC's Fiscal Year is From January To December - All Figures are in USD, Billions.
The item "Total-Long-Term-Liabilities" stands at 34.43 Billion United States Dollars as of 09/30/2025.
As of the end of AstraZeneca PLC's third quarter, the item "Total Long Term Liabilities" stands at 34.43 Billion USD. This represents an increase of 1.04 percent compared to it's value at the end of it's second quarter .
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -9.85 percent compared to the value the year prior.
The 1 year change in percent is -9.85.
The 3 year change in percent is 0.7314.
The 5 year change in percent is 9.12.
The 10 year change in percent is 66.22.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Total Long Term Liabilities | 905,699,262,464.00 |
![]() | Johnson & Johnson - Total Long Term Liabilities | 486,508,953,600.00 |
![]() | AbbVie Inc - Total Long Term Liabilities | 399,570,305,024.00 |
![]() | Roche Holding AG - Total Long Term Liabilities | 317,433,206,677.55 |
![]() | Novartis AG - Total Long Term Liabilities | 255,096,620,580.91 |